Abstract:The transcription factor MYC and its related family members MYCN and MYCL have been implicated in the etiology of a wide spectrum of human cancers. Compared to other oncoproteins, such as RAS or SRC, MYC is unique because its protein coding region is rarely mutated. Instead, MYC's oncogenic properties are unleashed by regulatory mutations leading to unconstrained high levels of expression. Under both normal and pathological conditions MYC regulates multiple aspects of cellular physiology including proliferation, differentiation, apoptosis, growth and metabolism by controlling the expression of thousands of genes. How a single transcription factor exerts such broad effects remains a fascinating puzzle. Notably, MYC is part of a network of bHLHLZ proteins centered on the MYC heterodimeric partner MAX and its counterpart, the MAX-like protein MLX. This network includes MXD1-4, MNT, MGA, MONDOA and MONDOB proteins. With some exceptions, MXD proteins have been functionally linked to cell cycle arrest and differentiation, while MONDO proteins control cellular metabolism. Although the temporal expression patterns of many of these proteins can differ markedly they are frequently expressed simultaneously in the same cellular context, and potentially bind to the same, or similar DNA consensus sequence. Here we review the activities and interactions among these proteins and propose that the broad spectrum of phenotypes elicited by MYC deregulation is intimately connected to the functions and regulation of the other network members. Furthermore, we provide a meta-analysis of TCGA data suggesting that the coordinate regulation of the network is important in MYC driven tumorigenesis. This article is part of a Special Issue entitled: Myc proteins in cell biology and pathology.

Of Myc and Mnt

Of Myc and Mnt

Mnt takes control as key regulator of the myc/max/mxd network

Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis

Ire1 Alpha Rnase-Dependent Lipid Homeostasis Promotes Survival In Myc-Transformed Cancers

Regulation of Normal and Neoplastic Proliferation and Metabolism by the Extended Myc Network

Myc beyond Cancer: Regulation of Mammalian Tissue Regeneration

MYC Binding Near Transcriptional End Sites Regulates Basal Gene Expression, Read-Through Transcription and Intragenic Contacts

MYC dephosphorylation by the PP1/PNUTS phosphatase complex regulates chromatin binding and protein stability

Transcriptional regulation by MYC: an emerging new model

MYC on the Path to Cancer

Elucidation of the structural determinants responsible for the specific formation of heterodimeric Mxd1/Max b-HLH-LZ and its binding to E-box sequences

Targeting oncogenic Myc as a strategy for cancer treatment

MAX inactivation deregulates the MYC network and induces neuroendocrine neoplasia in multiple tissues

Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis

Tumor Cell-Selective Regulation Of Noxa By C-Myc In Response To Proteasome Inhibition

Target gene-independent functions of MYC oncoproteins

Chromatin remodeling: recruitment of histone demethylase RBP2 by Madl for transcriptional repression of a Myc target gene, telomerase reverse transcriptase

Myc controls NK cell development, IL-15-driven expansion, and translational machinery

Myc inhibition impairs autophagosome formation

Myc inhibition tips the immune balance to promote antitumor immunity